Talajic M - Search Results

1

Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.

Gillis AM, Kerr CR, Philippon F, Newton G, Talajic M, Froeschl M, Froeschl S, Swiggum E, Yetisir E, Wells GA, Tang AS. Gillis AM, et al. Among authors: talajic m. Circulation. 2014 May 20;129(20):2021-30. doi: 10.1161/CIRCULATIONAHA.112.000417. Epub 2014 Mar 7. Circulation. 2014. PMID: 24610807 Clinical Trial.

2

Effects of beta-adrenergic receptor stimulation and blockade on rate-dependent atrioventricular nodal properties.

Nayebpour M, Talajic M, Nattel S. Nayebpour M, et al. Among authors: talajic m. Circ Res. 1992 May;70(5):902-11. doi: 10.1161/01.res.70.5.902. Circ Res. 1992. PMID: 1348976

3

Rate-dependent effects of diltiazem on human atrioventricular nodal properties.

Talajic M, Lemery R, Roy D, Villemaire C, Cartier R, Coutu B, Nattel S. Talajic M, et al. Circulation. 1992 Sep;86(3):870-7. doi: 10.1161/01.cir.86.3.870. Circulation. 1992. PMID: 1516199

4

Success, safety, and late electrophysiological outcome of low-energy direct-current ablation in patients with the Wolff-Parkinson-White syndrome.

Lemery R, Talajic M, Roy D, Coutu B, Lavoie L, Lavallée E, Cartier R. Lemery R, et al. Among authors: talajic m. Circulation. 1992 Mar;85(3):957-62. doi: 10.1161/01.cir.85.3.957. Circulation. 1992. PMID: 1537132

5

In vitro and in vivo effects within the coronary sinus of nonarcing and arcing shocks using a new system of low-energy DC ablation.

Lemery R, Leung TK, Lavallée E, Girard A, Talajic M, Roy D, Montpetit M. Lemery R, et al. Among authors: talajic m. Circulation. 1991 Jan;83(1):279-93. doi: 10.1161/01.cir.83.1.279. Circulation. 1991. PMID: 1984886

6

Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.

Ranger S, Talajic M, Lemery R, Roy D, Villemaire C, Nattel S. Ranger S, et al. Among authors: talajic m. Circulation. 1991 Jun;83(6):1987-94. doi: 10.1161/01.cir.83.6.1987. Circulation. 1991. PMID: 2040051

7

Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade.

Ranger S, Talajic M, Lemery R, Roy D, Nattel S. Ranger S, et al. Among authors: talajic m. Circulation. 1989 May;79(5):1000-6. doi: 10.1161/01.cir.79.5.1000. Circulation. 1989. PMID: 2540920

8

Depression and 18-month prognosis after myocardial infarction.

Frasure-Smith N, Lespérance F, Talajic M. Frasure-Smith N, et al. Among authors: talajic m. Circulation. 1995 Feb 15;91(4):999-1005. doi: 10.1161/01.cir.91.4.999. Circulation. 1995. PMID: 7531624

9

Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.

Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S. Wang J, et al. Among authors: talajic m. Circulation. 1993 Sep;88(3):1030-44. doi: 10.1161/01.cir.88.3.1030. Circulation. 1993. PMID: 8353865

10

Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation.

Kerr C, Boone J, Connolly S, Greene M, Klein G, Sheldon R, Talajic M. Kerr C, et al. Among authors: talajic m. Eur Heart J. 1996 Jul;17 Suppl C:48-51. doi: 10.1093/eurheartj/17.suppl_c.48. Eur Heart J. 1996. PMID: 8809539 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters